Advanced Therapies for Retinal Vascular Diseases: Enhancing Durability and Reducing Treatment Burden : Episode 4
Opinion
Video
MOA and Improved Outcomes: Gaps in Measuring Real-World Results
Author(s):
Sumit Sharma, MD, FASRS ponders to the panel the root cause of improved outcomes with newer agents. The panel then highlights current gaps in measuring visual improvements beyond tools such as the OCT, emphasizing the need for patient-centered treatment plans.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
